Icon PLC

ICLR

Equity

ISIN IE0005711209 / Valor 1017575

NASDAQ (2026-06-01)

USD 138.03+1.44%

Icon PLC
UMushroom community rating:

2.00 1 votes No rating yet

NegativeNeutralPositive

About company

ICON plc is a leading global provider of outsourced drug and medical device development and commercialization services, catering to pharmaceutical, biotechnology, and medical device companies as well as government and public health organizations. The company specializes in managing the entire product lifecycle, including the planning, execution, and analysis of Phase I-IV clinical trials, which range from small single-site studies to large, multinational projects and advancements in cell and gene therapy. ICON also offers Functional Service Provision (FSP), delivering essential support services in areas such as finance, IT, human resources, sales, quality assurance, facilities, administration, legal, and procurement. With over 13,000 employees and more than 90 global partnerships, ICON integrates its Strategic Solutions teams within clients' operations to enhance efficiency and accelerate the market entry of new therapeutics and devices. Additionally, ICON is committed to developing talent through various early career programs, fostering a culture of continuous learning and professional growth.

Summarized from source with an LLMView SourceSector: Healthcare

Aleenah Moghal

United Kingdom, 17 Feb 2026

Icon PLC faces significant uncertainty ue to an ongoing investigation into potential revenue overstatements for 2023–2025. this has led to significant price drops observed due to allegations that ICON plc may have issued materially misleading business information to the investing public.

EQUITIES OF THE SAME SECTOR

Elekta AB